Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center PRostate Cancer Individual Signature Evaluation Trial (PReCISE) in Patients Undergoing Scheduled Prostate Biopsy

NCT00966095 is registered in ClinicalTrials.gov with Source MDx as lead sponsor.

NCT NCT00966095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00966095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center PRostate Cancer Individual Signature Evaluation Trial (PReCISE) in Patients Undergoing Scheduled Prostate Biopsy
Lead sponsor
Source MDx
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2009
Completion date
Not reported
Enrollment
1,200 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer